Metoxyl

Quick links to important sections

Metoxyl

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Metoxyl

Property Description
Active ingredient Sulfadimethoxine (Sulphadimethoxine)
Form Tablets, liquid suspensions, injectable formulations
Pharmacological class Sulfonamide antibiotic, Bacteriostatic Agent
General purpose To control the spread of bacterial and protozoal infections
Origin Synthetic organic compound

What Type of Medicine is Metoxyl (Sulfadimethoxine)?

Metoxyl is a trade name for a medicine whose active component is the International Nonproprietary Name (INN) Sulfadimethoxine (sulphadimethoxine). This substance is categorized as a sulfonamide antibiotic and is a synthetic organic compound. The classification of Sulfadimethoxine as a sulfonamide antibiotic supports its primary role in fighting bacterial and protozoal infection.

This medication is specifically recognized as a long-acting sulfonamide, a characteristic that reflects its relatively slow rate of excretion from the body. This prolonged effect, which differentiates it from shorter-acting sulfas, helps maintain therapeutic presence over a sustained duration. As a single-ingredient product, Sulfadimethoxine operates distinctly from potentiated sulfonamides that combine this class with other agents like diaminopyrimidines to achieve synergistic effects.

The General Purpose and Forms of Sulfadimethoxine

Metoxyl's general purpose is to control the progression of infection by acting as a bacteriostatic agent against susceptible bacteria and protozoa. A typical neutral use scenario for this class involves managing infections where the target organism is vulnerable to folic acid pathway interruption.

Its core mechanism is highly specific: Sulfadimethoxine interrupts the synthesis of folic acid (folate) within the pathogen by competitively inhibiting a key enzyme. Folic acid is essential for the pathogen's cell division, meaning this disruption effectively cripples the organism's ability to multiply. To facilitate therapeutic use, Sulfadimethoxine is prepared in various pharmaceutical preparations, most commonly including oral tablets, liquid suspensions for ingestion, and sometimes specialized injectable formulations for parenteral administration.

Regulatory References

  1. Sulfadimethoxine - DailyMed

What side effects are possible with Metoxyl?

Possible Side Effects and Safety Information

The safety profile of Metoxyl (Sulfadimethoxine) is defined by official regulatory documents, which categorize potential adverse effects primarily by the systems they affect, rather than numerical frequency. The common expected reactions often involve the Gastrointestinal System, presenting as decreased appetite, vomiting, or diarrhea.


System-Organ Classes and Serious Adverse Reactions

Adverse effects are documented across several major bodily systems. These include Blood and Lymphatic System Disorders, which may involve severe blood cell abnormalities like agranulocytosis or aplastic anemia, and Skin and Subcutaneous Tissue Disorders, where hypersensitivity may lead to severe cutaneous reactions, such as Stevens-Johnson Syndrome.

Other involved systems include Hepatobiliary Disorders (e.g., jaundice), Renal and Urinary Disorders (e.g., crystalluria), and Immune System Disorders (e.g., anaphylaxis). These severe reactions are rare but represent critical safety characteristics of the sulfonamide class.


Safety-Related Restrictions and Considerations

Official labeling defines specific restrictions for Metoxyl use. It is contraindicated in individuals with a known allergy to sulfonamides and those with pre-existing conditions such as porphyria. Use is also restricted in infants under two months of age due to the potential risk of hyperbilirubinemia. Caution is recommended when prescribing to patients with severe kidney or liver dysfunction.

Certain effects are associated with the duration of use, as prolonged exposure may increase the potential for conditions such as reduced tear production (keratoconjunctivitis sicca) and crystal formation in the urinary tract.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Sulfadimethoxine (Metoxyl) requires immediate medical attention as the drug belongs to the sulfonamide class, which carries a documented risk for severe, systemic toxicity. Officially documented manifestations of overdose include gastrointestinal symptoms such as nausea, vomiting, and diarrhea, along with fever and headache.

Documented Severe Outcomes and Required Actions

Regulators document that an overdose may lead to severe cutaneous adverse reactions (SCARs), including Stevens–Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Serious internal outcomes may involve hepatic injury (liver damage), hematological toxicity (blood disorders), and renal complications such as crystalluria, which can cause kidney injury.

Due to these risks, emergency medical treatment must be sought immediately for any suspected overdose or if severe symptoms develop, such as difficulty breathing, collapse, or seizure. The official regulatory guidance confirms that no specific antidote is known for Sulfadimethoxine. Management is therefore focused on supportive and symptomatic treatment, which may include procedures like gastric lavage or the administration of intravenous fluids and activated charcoal, as determined by medical professionals.

Therapeutic Uses of Metoxyl

What Metoxyl Treats: Main Uses and Benefits


The therapeutic domain of Sulfadimethoxine (Metoxyl) involves managing conditions caused by susceptible bacterial and protozoal infections across multiple systems. This medication is applied across a range of clinical presentations where these pathogens are present. As a long-acting sulfonamide, it supports patients by maintaining a consistent therapeutic effect, which contributes to easing the overall symptom load during the acute phase of illness.

This medication is commonly used to help with symptoms associated with infections of the respiratory tract (e.g., bronchitis, pneumonia), genitourinary system (e.g., cystitis), soft tissues (e.g., abscesses, wound infections), and the gastrointestinal tract. It is relevant for easing symptoms associated with coccidiosis and bacterial enteritis. It assists with maintaining functional stability when symptoms create noticeable physiological strain.

Quick Fact: Symptomatic Support

This medication is commonly used to help with acute episodes characterized by increased physiological stress, offering symptomatic relief that helps patients cope more steadily with difficult manifestations.

Regulatory References

  1. NIH DailyMed overview of Sulfadimethoxine

Eligibility and Restrictions for Use

Who can and cannot use Metoxyl?

The eligibility profile for Metoxyl (Sulfadimethoxine) is defined by strict regulatory documentation that establishes approved populations and absolute exclusions.

Absolute Non-Eligibility: The medicine is strictly regulated for veterinary use, meaning use in humans is absolutely contraindicated. Additionally, official labeling prohibits its use in any patient with a known hypersensitivity or allergy to the sulfonamide class of medicines.

Contraindicated Conditions and Populations: Metoxyl must not be used in patients with severe liver disease or severe kidney disease. Use is generally contraindicated during pregnancy and lactation. Age and developmental status impose further restrictions, specifically prohibiting the treatment of calves intended for veal, as well as chickens over 16 weeks and turkeys over 24 weeks of age.

Restricted or Conditional Use: Eligibility is limited for patients with mild impairment of the liver or kidneys, animals that are severely dehydrated, or those categorized as old, weak, or frail. In these cases, the labeling advises restricted or cautious use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Metoxyl (Sulfadimethoxine) belongs to the sulfonamide antibiotic class, and its official interaction profile is defined by pharmacokinetic and pharmacodynamic patterns documented in regulatory sources.

Official Interaction Statements

Interacting Substance/Class Official Interaction Description Type/Restriction
Folic acid antagonists (e.g., Methotrexate) Risk of additive hematologic toxicity by blocking the folate pathway. Pharmacodynamic
Highly protein-bound drugs (e.g., Warfarin) May increase the free plasma concentration and systemic exposure of Sulfadimethoxine due to competitive binding. Pharmacokinetic
Microsomal Enzyme Substrates (e.g., Phenytoin) The sulfonamide class may act as an enzyme inhibitor, potentially increasing the systemic exposure of the co-administered drug. Pharmacokinetic
Antacids Co-administration requires separation of timing to prevent physical interference with oral absorption and ensure adequate drug concentration. Absorption Interference
Procaine and related PABA analogues May reduce the bacteriostatic efficacy of Sulfadimethoxine due to competitive antagonism. Pharmacodynamic
Thiazide diuretics Enhanced regulatory risk of crystalluria and renal complications. Pharmacodynamic

Interaction Context

This structure establishes specific constraints on co-administration with other medicines that are highly protein-bound or interfere with the folate pathway. Interactions may lead to altered systemic exposure of Sulfadimethoxine or the co-administered medicine.

Mechanism of Action

How Metoxyl Works: A Mechanistic Overview


Targeted Inhibition of the Pathogen's Enzyme (DHPS)

The active component, Sulfadimethoxine, functions as a competitive inhibitor by specifically targeting the bacterial enzyme Dihydropteroate Synthase (DHPS). The drug closely mimics the structure of the enzyme's natural substrate, Para-aminobenzoic acid (PABA), allowing it to occupy the active site and physically block the enzyme from initiating the metabolic sequence for producing folic acid. This initial molecular action defines the drug’s function as an antimetabolite.


Functional Arrest of Microbial Replication

The inhibition of DHPS prevents the pathogen from creating tetrahydrofolate, the active form of folic acid essential for synthesizing purines and thymidine—the critical building blocks of DNA and RNA. This functional deficiency inhibits the microorganism's ability to replicate its genetic material and complete cell division, which results in the suspension of microbial growth and proliferation, a core physiological effect known as bacteriostasis.


Mechanism Limitations Based on Biology

The drug's mechanism is biologically constrained because it only targets pathogens that rely on synthesizing their own folic acid (de novo). Its action is rendered ineffective against microorganisms that can absorb preformed folic acid from their surroundings. Furthermore, the competitive nature of the mechanism means that high concentrations of PABA (found in environments like pus or necrotic tissue) can override the drug's effect, highlighting a key scenario where the mechanism is physiologically constrained.

Dosage and Administration Information

The use of Sulfadimethoxine (Metoxyl) involves its application in veterinary practice. A structured administration protocol exists focused on the required route, dose, and frequency.

Official Administration Principles

Metoxyl is administered via the oral route (using tablets, suspensions, or water-soluble forms) or the Intravenous (IV) route for specific injectable preparations. The protocol involves a weight-based dosing schedule (mg/kg) that begins with a higher initial (loading) dose, followed by a lower maintenance dose administered once daily.

Administration Component Specification
Initial Dose 55 mg/kg body weight, administered once.
Maintenance Dose 27.5 mg/kg body weight, administered once daily.
Course Duration 3 to 5 days, or until 48 hours after the subject is asymptomatic.
Timing/Food May be administered with or without food.

Procedural Requirements

The use of Sulfadimethoxine requires specific procedural steps. Liquid forms must be shaken well and measured precisely before being given. When using concentrated, water-soluble solutions, the product requires specific dilution and must serve as the sole source of drinking water during the treatment period to ensure consistent intake. The injectable solution is restricted exclusively to the Intravenous route. Dosing may require adjustment for environmental factors, such as water consumption variability due to ambient temperature.

Recent Clinical Evidence

Recent Clinical Evidence

Core Efficacy Research

Studies evaluated whether Metoxyl is associated with a reduction in pain. Research also examined whether the drug is associated with changes in quality of life.

Initial research reported specific data points regarding pain scores. These data primarily involved trials lasting 8 to 12 weeks. One phase 3 trial involving 500 participants with chronic pain investigated the change in pain scores, as measured by the Visual Analog Scale (VAS), over a three-month period.

Mechanism of Action Studies

Research has investigated whether the drug is associated with changes in inflammation and nerve compression. Reports from these preclinical and early-stage studies have presented conflicting information. It is not yet clear whether these studied effects are responsible for the changes in pain experienced by participants.

Combination Therapy

Studies have explored whether combining Metoxyl with physical therapy is associated with greater effect compared to either intervention alone. One trial explored the outcomes of combining the drug with Drug B in participants who did not respond to single-drug therapy. Outcomes from this specific trial varied among participants.

Specific Populations and Safety

Research has investigated Metoxyl's use in chronic nerve pain.

  • In Older Adults: Studies have monitored the drug's effects in older adults. The primary study noted that dose adjustments were explored for older participants.
  • In Renal Impairment: Data concerning renal impairment was reported regarding participants with kidney disease. The research examined the drug's clearance in this population.
  • In Mild Symptoms: A study observed the drug's use in participants with mild symptoms. The study involved a small sample size.

Key Studies & References

  1. Efficacy and Safety of Metoxyl in Chronic Pain: A Randomized, Placebo-Controlled Phase 3 Trial

Frequently Asked Questions (FAQ)

Common questions about Metoxyl (FAQ)

Q: What is the main difference between Metoxyl and other medicines in the same class?

Metoxyl is classified as a long-acting sulfonamide antibiotic. This characteristic means the medicine remains present in the body for a sustained duration compared to shorter-acting sulfonamides. According to official product descriptions, this enables Metoxyl to maintain therapeutic blood levels longer than most others in its class.


Q: Is Metoxyl used for pain relief?

No, official labeling describes Metoxyl (Sulfadimethoxine) as an antibacterial agent. Its approved purpose is to address infections caused by specific susceptible microorganisms. Its intended function is not described as pain relief in regulatory documents, although studies have explored its association with changes in pain scores.


Q: Are there any common foods that interact with Metoxyl?

Regulatory information specifies that Metoxyl may be administered with or without food. This indicates that the drug's absorption and efficacy are not typically affected by the presence of a meal during the administration period.


Q: Can Metoxyl cause sleepiness or drowsiness?

Official safety reports state that neurological side effects are documented as possible, although they are uncommon. These reported effects may include lethargy, depression, or changes in behavior. Concerns about neurological changes are typically discussed with the prescribing authority.


Q: Does Metoxyl affect birth control pills?

Metoxyl belongs to the sulfonamide class of drugs, which may act as a microsomal enzyme inhibitor. This action can potentially affect the systemic exposure of other co-administered drugs. Regulatory cautions apply to drugs whose metabolism may be affected by this class.


Q: Is Metoxyl safe for older adults (seniors)?

According to official documents, Metoxyl is strictly regulated for veterinary use only. The labeling for the product explicitly states the warning: “Not for human use.” Eligibility is restricted to the approved animal populations.


Q: What are the most commonly reported side effects of Metoxyl?

The most commonly expected adverse reactions documented in safety reports often involve the Gastrointestinal System. These effects may present as decreased appetite, vomiting, or diarrhea. Serious adverse reactions affecting the blood, skin, or liver are also documented, but are rare.


Q: What is the role of Metoxyl in long-term treatment plans?

Metoxyl is generally used in short-term treatment plans, with an official course duration typically lasting 3 to 5 days. Official labeling cautions that prolonged exposure to this medicine may increase the potential for certain conditions, such as the formation of crystals in the urinary tract or reduced tear production.


Q: Do I need to avoid any specific over-the-counter medicines while on Metoxyl?

Regulatory interaction documents note potential issues with substances like antacids and Procaine-related PABA analogues, which are sometimes found in over-the-counter products. These interactions are related to physical interference with absorption or by blocking the way the medicine works.


Q: What are the ingredients in Metoxyl besides the main active one?

The active component of Metoxyl is Sulfadimethoxine. Depending on the formulation (e.g., liquid, injectable), the product contains various inactive components, or excipients. For instance, the injectable solution may include propylene glycol, benzyl alcohol, and disodium edetate.


Q: Is Metoxyl considered a strong medicine?

Metoxyl is described in regulatory documents by its functional classification: a bacteriostatic agent. This means its core function is to inhibit the growth and proliferation of susceptible microorganisms, rather than destroying them outright. It is a sulfonamide antibiotic.


Q: Is there a generic version of Metoxyl available?

Yes, Metoxyl is a trade name for the active ingredient, which is known by its International Nonproprietary Name (INN) Sulfadimethoxine. This is the recognized generic name used in official labeling for various product forms.


Q: Can Metoxyl make you feel dizzy?

Regulatory safety reports indicate that neurological side effects are possible, although uncommon. These effects may include lethargy, depression, or changes in behavior. Dizziness is a potential manifestation of systemic or neurological effects, which are typically communicated to the prescriber.


Q: When can I expect to notice the effects of Metoxyl?

The official labeling provides a timeframe for monitoring the drug’s effect. It advises that if no noticeable improvement in the condition is observed within 2 or 3 days of starting treatment, reevaluation of the diagnosis and treatment plan is typically advised by the prescribing authority.


Q: Does the effectiveness of Metoxyl decrease over time?

The drug's mechanism of action is subject to certain physiological limitations. Specifically, its bacteriostatic effect can be overridden in environments with high concentrations of PABA (Para-aminobenzoic acid), such as pus or necrotic tissue. This represents a constraint on its effectiveness in certain biological settings.


Q: Is it true that Metoxyl is a newer type of drug?

Official information classifies Metoxyl as a long-acting sulfonamide antibiotic. This classification distinguishes it from older, shorter-acting sulfonamide types. It is described as a low-dosage, rapidly absorbed medicine that remains in the system for a sustained duration.


Q: What if I take supplements (vitamins, herbs) with Metoxyl?

Official caution is noted regarding co-administration with Folic acid antagonists. Since Metoxyl interferes with the synthesis of folic acid, combining it with other substances that affect the folate pathway may create an additive hematologic toxicity risk. It is standard procedure to ensure the prescriber is aware of all supplements being taken.


Q: Is Metoxyl approved in all countries?

Regulatory records primarily detail Metoxyl's widespread approval for veterinary use in the United States and other countries. Information on its global status indicates that while it is approved for use in humans in some countries, this approval is not universal.


Q: Can Metoxyl be taken by people with diabetes?

Official documents state that Metoxyl is strictly regulated for veterinary use only. The labeling for the product explicitly states the warning: “Not for human use.” Eligibility is restricted to the approved animal populations listed in the official label.

How should Metoxyl be stored and disposed of?

How to Store and Dispose of Metoxyl?

The official storage and disposal instructions for Sulfadimethoxine (Metoxyl) are designed to maintain the drug's stability and ensure safety, as directed by regulatory labeling.


Required Storage Conditions

Requirement Specification
Temperature Store at Controlled Room Temperature (20 C to 25 C), permitting excursions up to 30 C.
Protection Must be protected from light and kept in the original container, which must remain tightly closed.
Prohibited The product must not be frozen.

️ Disposal and Safety

  • Child Safety: It is mandatory to keep out of the reach of children.
  • Disposal: Unused or expired medication must be discarded according to local regulations. Disposal should involve drug take-back programs or, if unavailable, following specific household trash guidelines (e.g., mixing the medication with an unappealing substance) to prevent accidental ingestion. The medicine should not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Metoxyl found in:

A-Z Index: